| Metric | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ |
|---|---|---|---|---|
| Revenue | — | — | — | — |
| Cost of Revenue | — | — | — | — |
| Gross Profit | — | — | — | — |
| R&D Expense | — | — | — | — |
| SG&A Expense | — | — | — | — |
| Operating Income | — | — | — | — |
| Net Income | $0.1B | $0.1B | $0.1B | $0.0B |
| EPS (Basic) | $2.76 | $4.15 | $2.55 | $2.36 |
| EPS (Diluted) | $2.69 | $4.08 | $2.48 | $2.30 |
| Metric | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ |
|---|---|---|---|---|
| Total Assets | $8.1B | $7.9B | $7.4B | $5.7B |
| Current Assets | — | — | — | — |
| Cash & Equivalents | $0.6B | $0.5B | $0.3B | $0.7B |
| Total Liabilities | $7.1B | $7.0B | $6.7B | $5.1B |
| Current Liabilities | — | — | — | — |
| Stockholders' Equity | $1.0B | $0.9B | $0.8B | $0.5B |
| Metric | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ |
|---|---|---|---|---|
| Operating Cash Flow | $0.1B | $0.1B | $0.1B | $0.1B |
| Investing Cash Flow | $-0.1B | $-0.3B | $-0.5B | $-0.3B |
| Capital Expenditures | $0.0B | $0.0B | $0.0B | $0.0B |
| Financing Cash Flow | $0.1B | $0.3B | $0.1B | $0.6B |